ASO Author Reflections: Discordant Pathology in Pseudomyxoma Peritonei and Its Impact on Survival following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

被引:0
|
作者
Chintamani Godbole
Ayaz Ahmed Memon
Norman John Carr
机构
[1] Peritoneal Malignancy Institute,
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2614 / 2615
页数:1
相关论文
共 50 条
  • [41] Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin
    Jarvinen, Petrus
    Ristimaki, Ari
    Kantonen, Jonas
    Aronen, Merja
    Huuhtanen, Riikka
    Jarvinen, Heikki
    Lepisto, Anna
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014, 29 (08) : 999 - 1007
  • [42] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?
    Lopez-Lopez, V.
    Cascales-Campos, P. A.
    Gil, E.
    Arevalo, J.
    Gonzalez, A.
    Gil, J.
    Munoz-Casares, F. C.
    Melero, J. T.
    Barrios, P.
    Morales, R.
    Ramos, I.
    Ortega, G.
    Camps, B.
    Gonzalez-Bayon, L.
    Bretcha-Boix, P.
    Farre-Alegre, J.
    Gonzalez-Moreno, S.
    Parrilla, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (11): : 1388 - 1392
  • [43] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?
    V. López-López
    P. A. Cascales-Campos
    E. Gil
    J. Arevalo
    A. Gonzalez
    J. Gil
    F. C. Muñoz-Casares
    J. T. Melero
    P. Barrios
    R. Morales
    I. Ramos
    G. Ortega
    B. Camps
    L. González-Bayón
    P. Bretcha-Boix
    J. Farré-Alegre
    S. González-Moreno
    P. Parrilla
    Clinical and Translational Oncology, 2017, 19 : 1388 - 1392
  • [44] ASO Author Reflections: Disparate Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Based on Insurance Status
    Hanna, David N.
    Magge, Deepa
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 260 - 261
  • [45] ASO Author Reflections: Disparate Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Based on Insurance Status
    David N. Hanna
    Deepa Magge
    Annals of Surgical Oncology, 2022, 29 : 260 - 261
  • [46] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report
    Ebbe Billmann Thorgersen
    Espen Melum
    Trine Folseraas
    Stein Gunnar Larsen
    Pål Dag Line
    World Journal of Surgical Oncology, 16
  • [47] PSEUDOMYXOMA PERITONEI: PATHOLOGICAL CLASSIFICATION AND CLINICAL OUTCOME OF PATIENTS TREATED BY CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
    Lopes, Andre
    Mello, Evandro S.
    Mendoza Lopez, Rossana Veronica
    Leonardi, Paulo C.
    Ribeiro, Ulysses
    GASTROENTEROLOGY, 2021, 160 (06) : S884 - S885
  • [48] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report
    Thorgersen, Ebbe Billmann
    Melum, Espen
    Folseraas, Trine
    Larsen, Stein Gunnar
    Line, Pal Dag
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [49] Anaesthetic management of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective audit
    Shiralkar, S. P.
    Kerr, P.
    Scottt, J.
    Sivalingam, P.
    ANAESTHESIA AND INTENSIVE CARE, 2017, 45 (04) : 490 - 498
  • [50] Thoracic Cytoreductive Surgery and Intraoperative Hyperthermic Intrathoracic Chemotherapy for Pseudomyxoma Peritonei
    Chua, Terence C.
    Yan, Tristan D.
    Yap, Zhu L.
    Horton, Matthew D.
    Fermanis, Gary G.
    Morris, David L.
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (05) : 292 - 295